19 research outputs found
Clinical Outcome Assessments in Encephalitis
Background and ObjectivesMost patients with encephalitis experience persisting neurocognitive and neuropsychiatric sequelae in the years following this acute illness. Reported outcomes are often based on generic clinical outcome assessments that rarely capture the patient perspective. This may result in an underestimation of disease-specific sequelae. Disease-specific clinical outcome assessments can improve clinical relevance of reported outcomes and increase the power of research and trials. There are no patient-reported outcome measures (PROMs) developed or validated specifically for patients with encephalitis. The primary objective of this systematic literature review was to identify PROMs that have been developed for or validated in patients with encephalitis. MethodsWe performed a systematic review of the literature published from inception until May 2023 in 3 large international databases (MEDLINE, EMBASE and Cochrane libraries). Eligible studies should have developed or validated a PROM in patients with encephalitis or encephalopathy. Methodologic quality was evaluated using the Consensus-based Standards for the selection of health status Measurement Instruments study design checklist for PROMs. ResultsWe identified no disease-specific PROMs developed or validated for patients with encephalitis. We identified one study on the development and validation of a disease-specific PROM for hepatic encephalopathy, although this disease course is substantially different to that of patients with encephalitis. The methodologic quality of the included study was generally rated as "doubtful." We identified 30 PROMs that have been applied in 46 studies on encephalitis or encephalopathy, although not validated in these populations. The most commonly applied PROMs for measuring Health-Related Quality of Life were the Medical Outcomes Study Short Form-36 and the Sickness Impact Profile. Emotional well-being was often assessed with the Beck Depression Inventory (BDI-II). Sporadically, PROMs were applied to address other aspects of outcome including daily functioning and sleep quality. DiscussionThis systematic review confirms a critical gap in clinical outcome assessments in patients with encephalitis, failing to identify a validated measuring tool for detecting neurocognitive, functional, and health status. It is therefore essential to develop and/or validate disease-specific PROMs for the population with encephalitis to capture relevant information for patient management and clinical trials about the effects of disease that are at risk of being overlooked.</p
Diagnosis and management of Guillain-Barré syndrome in ten steps
Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline is based on current literature and expert consensus, and has a ten-step structure to facilitate its use in clinical practice. We first provide an introduction to the diagnostic criteria, clinical variants and differential diagnoses of GBS. The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae
GuĂa basada en la evidencia. DiagnĂłstico y manejo del sĂndrome de Guillain-BarrĂ© en diez pasos = Evidence based guidelines. Diagnosis and management of Guillain-BarrĂ© syndrome in ten steps
Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and in 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline is based on current literature and expert consensus, and has a ten-step structure to facilitate its use in clinical practice. We first provide an introduction to the diagnostic criteria, clinical variants and differential diagnoses of GBS. The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae
Diagnosis and management of GuillainâBarrĂ© syndrome in ten steps
GuillainâBarrĂ© syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline is based on current literature and expert consensus, and has a ten-step structure to facilitate its use in clinical practice. We first provide an introduction to the diagnostic criteria, clinical variants and differential diagnoses of GBS. The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae
X-ray Polarization Observations of BL Lacertae
Blazars are a class of jet-dominated active galactic nuclei with a typical
double-humped spectral energy distribution. It is of common consensus the
Synchrotron emission to be responsible for the low frequency peak, while the
origin of the high frequency hump is still debated. The analysis of X-rays and
their polarization can provide a valuable tool to understand the physical
mechanisms responsible for the origin of high-energy emission of blazars. We
report the first observations of BL Lacertae performed with the Imaging X-ray
Polarimetry Explorer ({IXPE}), from which an upper limit to the polarization
degree 12.6\% was found in the 2-8 keV band. We contemporaneously
measured the polarization in radio, infrared, and optical wavelengths. Our
multiwavelength polarization analysis disfavors a significant contribution of
proton synchrotron radiation to the X-ray emission at these epochs. Instead, it
supports a leptonic origin for the X-ray emission in BL Lac.Comment: 17 pages, 5 figures, accepted for publication in ApJ
Discovery of X-ray polarization angle rotation in active galaxy Mrk 421
The magnetic field conditions in astrophysical relativistic jets can be
probed by multiwavelength polarimetry, which has been recently extended to
X-rays. For example, one can track how the magnetic field changes in the flow
of the radiating particles by observing rotations of the electric vector
position angle . Here we report the discovery of a
rotation in the X-ray band in the blazar Mrk 421 at an average flux state.
Across the 5 days of Imaging X-ray Polarimetry Explorer (IXPE) observations of
4-6 and 7-9 June 2022, rotated in total by .
Over the two respective date ranges, we find constant, within uncertainties,
rotation rates ( and ) and polarization
degrees (). Simulations of a random walk of the
polarization vector indicate that it is unlikely that such rotation(s) are
produced by a stochastic process. The X-ray emitting site does not completely
overlap the radio/infrared/optical emission sites, as no similar rotation of
was observed in quasi-simultaneous data at longer wavelengths. We
propose that the observed rotation was caused by a helical magnetic structure
in the jet, illuminated in the X-rays by a localized shock propagating along
this helix. The optically emitting region likely lies in a sheath surrounding
an inner spine where the X-ray radiation is released
Magnetic Field Properties inside the Jet of Mrk 421: Multiwavelength Polarimetry Including the Imaging X-ray Polarimetry Explorer
We conducted a polarimetry campaign from radio to X-ray wavelengths of the
high-synchrotron-peak (HSP) blazar Mrk 421, including Imaging X-ray Polarimetry
Explorer (IXPE) measurements on 2022 December 6-8. We detected X-ray
polarization of Mrk 421 with a degree of =141 and an
electric-vector position angle =1073 in the 2-8
keV band. From the time variability analysis, we find a significant episodic
variation in . During 7 months from the first IXPE pointing of
Mrk 421 in 2022 May, varied across the range of 0 to
180, while maintained similar values within
10-15. Furthermore, a swing in in 2022 June was
accompanied by simultaneous spectral variations. The results of the
multiwavelength polarimetry show that the X-ray polarization degree was
generally 2-3 times greater than that at longer wavelengths, while the
polarization angle fluctuated. Additionally, based on radio, infrared, and
optical polarimetry, we find that rotation of occurred in the opposite
direction with respect to the rotation of over longer timescales
at similar epochs. The polarization behavior observed across multiple
wavelengths is consistent with previous IXPE findings for HSP blazars. This
result favors the energy-stratified shock model developed to explain variable
emission in relativistic jets. The accompanying spectral variation during the
rotation can be explained by a fluctuation in the physical
conditions, e.g., in the energy distribution of relativistic electrons. The
opposite rotation direction of between the X-ray and longer-wavelength
polarization accentuates the conclusion that the X-ray emitting region is
spatially separated from that at longer wavelengths.Comment: 17 pages, 13 figures, 4 tables; Accepted for publication in A&
Neuromuscular rehabilitation - what to do?
PURPOSE OF REVIEW: Rehabilitation for patients with neuromuscular disorders (NMDs) has undisputed health benefits and is potentially therapeutic for targeting impairments, improving quality of life, and enabling activities of daily living. Whilst rehabilitation is commonly prescribed, unequivocal evidence and disease-related guidelines are lacking. This review highlights recent studies of exercise, assistive devices, respiratory management and manual therapy and stretching for patients with NMDs.
RECENT FINDINGS: Randomised controlled trials of neuromuscular rehabilitation are scant, often underpowered and lack a control group. Recent case studies, clinical trials and cohort studies support rehabilitative therapies such as exercise, respiratory muscle training, assistive devices, and manual therapy and stretching, to provide systemic health benefits, with the possibility to retain or improve function. No evidence of overwork weakness or muscle damage have been reported in exercise trials, and rehabilitative exercise programs in many cases lead to positive psychosocial impacts. Tele-rehab is an emerging area of interest, as a response to the COVID-19 pandemic.
SUMMARY: Robust evidence for the benefits of neuromuscular rehabilitation is lacking, and clinical trial quality can be improved. Tele-rehab is a tantalising development to improve access to neuromuscular rehabilitation in both metropolitan and remote settings during and beyond the COVID-19 pandemic